Search Results
You are looking at 1 - 4 of 4 items for
- Author: J C Ho x
- Refine by access: All content x
Search for other papers by FU-HO C. CHOW in
Google Scholar
PubMed
Search for other papers by KATHLEEN J. HANSON in
Google Scholar
PubMed
Search for other papers by D. W. HAMAR in
Google Scholar
PubMed
Search for other papers by R. H. UDALL in
Google Scholar
PubMed
Colorado residents of long standing can recall the legend that Indian women used to take an aqueous extract of pine needles to induce abortion. The effects of pine needle ingestion on pregnancy of cattle and mice have been reported by Bruce (1927), MacDonald (1952), Deem, Osborn & Maag (1959, unpublished data reported by Faulkner, 1968), Allen & Kitts (1961), and Cook & Kitts (1964), but the active agent and the effect on reproduction have not been defined. The object of this investigation was to isolate the agent which affects reproduction.
Three fractions (volatile, water-soluble and acetone-soluble) were prepared from needles of yellow pine (Pinus ponderosa) collected from Rist Canyon, west of Fort Collins, Colorado, and stored in plastic bags at −20° C. Fractions were prepared as follows.
Search for other papers by C. Behrens in
Google Scholar
PubMed
Search for other papers by J. E. Aurich in
Google Scholar
PubMed
Search for other papers by E. Klug in
Google Scholar
PubMed
Search for other papers by H. Naumann in
Google Scholar
PubMed
Search for other papers by H-O. Hoppen in
Google Scholar
PubMed
Effects of the opioid antagonist naloxone on concentrations of LH and FSH in plasma were measured in mares during different stages of the oestrous cycle. During the follicular phase of the cycle, naloxone (300 mg i.v.) had no discernible effects on basal concentrations of LH and FSH. A significant increase in plasma LH (P < 0.01) and FSH (P < 0.05) concentrations was observed after naloxone in mares during the luteal phase. This response was not different between suckled and non-suckled mares. The gonadotrophin-releasing hormone analogue buserelin (0.02 mg i.v.) caused a significant (P < 0.05) LH and FSH release irrespective of the stage of the oestrous cycle and a previous naloxone treatment. The results of this study indicate that endogenous opioid peptides are involved in the inhibition of LH and FSH release during the luteal phase of the oestrous cycle in mares and may partially mediate the suppressive influence of progesterone on gonadotrophin secretion. The opioid-mediated suppression of LH and FSH release does not seem to be affected by suckling.
Departments of, Anatomy, Physiology, Medicine, Center of Heart, Centre of Growth, Brain and Healthy Aging
Search for other papers by S B Liao in
Google Scholar
PubMed
Search for other papers by J C Ho in
Google Scholar
PubMed
Departments of, Anatomy, Physiology, Medicine, Center of Heart, Centre of Growth, Brain and Healthy Aging
Search for other papers by F Tang in
Google Scholar
PubMed
Departments of, Anatomy, Physiology, Medicine, Center of Heart, Centre of Growth, Brain and Healthy Aging
Search for other papers by W S O in
Google Scholar
PubMed
Our laboratory previously showed that oviduct produced the greatest amount of adrenomedullin (ADM) in the rat female reproductive tract. The aim of this study is to investigate the changes in ADM levels resulting from the contact between the sperm and the oviduct and the possible roles of ADM in ciliary beating and oviductal contractility. Oviducts from Sprague–Dawley rats removed at pre- and post-ovulatory stages were cut open longitudinally and treated with ADM and/or receptor blockers before ciliary beat frequency (CBF) was measured. The effects of sperm on ADM production and CBF in the oviduct were also determined. The contraction of the oviduct after treatment with ADM and receptor antagonists was measured using the organ-bath technique. The results showed that ADM increased the CBF in rat oviduct and this stimulating effect was blocked by the calcitonin-gene-related peptide (CGRP) receptor antagonist, hCGRP8–37. CBF was lower in post-ovulatory than pre-ovulatory oviducts. The presence of sperm in the oviduct increased both the ADM level and CBF. ADM treatment was shown to inhibit the contractility of the oviduct by lowering the basal tone and decreasing the contraction amplitude. The ADM receptor antagonist, hADM22–52, was effective in counteracting the relaxation effect of ADM in the oviduct. All in all, these results indicate that ADM may play a crucial role in transporting the gametes/embryos by regulating ciliary beating and muscular contraction.
Search for other papers by Joseph C Chen in
Google Scholar
PubMed
Search for other papers by Amy-Lynn Frankshun in
Google Scholar
PubMed
Search for other papers by Anne A Wiley in
Google Scholar
PubMed
Search for other papers by Dori J Miller in
Google Scholar
PubMed
Search for other papers by Kristene A Welch in
Google Scholar
PubMed
Search for other papers by Teh-Yuan Ho in
Google Scholar
PubMed
Search for other papers by Frank F Bartol in
Google Scholar
PubMed
Search for other papers by Carol A Bagnell in
Google Scholar
PubMed
Lactocrine communication of milk-borne bioactive factors (MbFs) from mother to offspring through nursing can affect neonatal development with lasting consequences. Relaxin (RLX), a lactocrine-active peptide found in porcine colostrum, stimulates estrogen receptor-α (ESR1) expression required for uterine development shortly after birth (postnatal day=PND 0). Whether other MbFs or cooperative lactocrine mechanisms affect the neonatal uterine developmental program is unknown. To determine the effects of age, nursing, and exogenous RLX on gene expression associated with uterine development, gilts (n=4–5/group) were assigned to nurse ad libitum or to receive milk replacer, with or without exogenous RLX (20 μg/kg BW i.m./6 h for 48 h), from birth to PND 2 when uteri were collected. Body weight and uterine weight increased (P<0.05) similarly from birth to PND 2 in all gilts. However, colostrum consumption was required for normal uterine ESR1, vascular endothelial growth factor (VEGFA), matrix metalloproteinase 9 (MMP9), and RLX receptor (RXFP1) protein and/or transcript expression on PND 2. Uterine ESR1, VEGFA, and MMP9 protein levels were below (P<0.01) the assay sensitivity in replacer-fed gilts. Supplemental RLX increased (P<0.05) uterine ESR1 protein and mRNA in nursed gilts, as well as VEGFA protein in nursed and VEGFA mRNA in both nursed and replacer-fed gilts. RLX treatment did not affect uterine MMP9 mRNA levels. When compared with replacer-fed gilts on PND 2, uterine RXFP1 mRNA was reduced (P<0.05) in nursed gilts and in RLX-supplemented replacer-fed gilts. These results constitute the first evidence that establishment of the neonatal porcine uterine developmental program requires maternal lactocrine support.
